These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 32364058)

  • 1. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
    Cubie HA; Campbell C
    Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of thermo-coagulation as an alternative treatment modality in a 'screen-and-treat' programme of cervical screening in rural Malawi.
    Campbell C; Kafwafwa S; Brown H; Walker G; Madetsa B; Deeny M; Kabota B; Morton D; Ter Haar R; Grant L; Cubie HA
    Int J Cancer; 2016 Aug; 139(4):908-15. PubMed ID: 27006131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
    Pimple SA; Mishra GA
    Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
    Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
    BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative approaches to cervical cancer screening in low- and middle-income countries.
    Toliman PJ; Kaldor JM; Tabrizi SN; Vallely AJ
    Climacteric; 2018 Jun; 21(3):235-238. PubMed ID: 29488817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cancer in low- and middle-income countries.
    Sankaranarayanan R
    Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Cervix Cancer in India.
    Mishra GA; Pimple SA; Shastri SS
    Oncology; 2016; 91 Suppl 1():1-7. PubMed ID: 27463969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial.
    Pinder LF; Parham GP; Basu P; Muwonge R; Lucas E; Nyambe N; Sauvaget C; Mwanahamuntu MH; Sankaranarayanan R; Prendiville W
    Lancet Oncol; 2020 Jan; 21(1):175-184. PubMed ID: 31734069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening in high- and low-resource countries: implications and new developments.
    Hoppenot C; Stampler K; Dunton C
    Obstet Gynecol Surv; 2012 Oct; 67(10):658-67. PubMed ID: 23112073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative approaches to cervical cancer screening for developing countries.
    Wright TC; Kuhn L
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):197-208. PubMed ID: 22385539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India.
    Saxena U; Sauvaget C; Sankaranarayanan R
    Asian Pac J Cancer Prev; 2012; 13(4):1699-703. PubMed ID: 22799391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment.
    Herrick T; Thomson KA; Shin M; Gannon S; Tsu V; de Sanjosé S
    BMC Health Serv Res; 2022 Oct; 22(1):1246. PubMed ID: 36241993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.
    Joseph J; Demke O; Ameyan L; Bitilinyu-Bango J; Bourgoin B; Diop M; Guèye B; Kama J; Lubega M; Madzima B; Maparo T; Mhizha T; Musoke A; Nabadda S; Phiri T; Tchereni T; Wiwa O; Hariharan K; Peter T; Khan S
    BMJ Open; 2023 Jan; 13(1):e065074. PubMed ID: 36609331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
    Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
    BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of approaches to cervical cancer screening in Malawi: comparison of frequencies, lesion treatment techniques, and risk-stratified approaches.
    Rasmussen PW; Hoffman RM; Phiri S; Makwaya A; Kominski GF; Bastani R; Moses A; Moucheraud C
    BMC Health Serv Res; 2024 Jul; 24(1):792. PubMed ID: 38982430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
    Campos NG; Sharma M; Clark A; Kim JJ; Resch SC
    PLoS One; 2016; 11(10):e0164000. PubMed ID: 27711124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities and challenges for introducing HPV testing for cervical cancer screening in sub-Saharan Africa.
    Tsu VD; Njama-Meya D; Lim J; Murray M; de Sanjose S
    Prev Med; 2018 Sep; 114():205-208. PubMed ID: 30031013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
    Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
    BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.